S&P 500 Futures
(-0.55%) 5 079.50 points
Dow Jones Futures
(-0.31%) 38 560 points
Nasdaq Futures
(-0.87%) 17 511 points
Oil
(-0.08%) $82.74
Gas
(-0.60%) $1.643
Gold
(-0.06%) $2 337.00
Silver
(0.12%) $27.38
Platinum
(0.01%) $915.90
USD/EUR
(-0.28%) $0.932
USD/NOK
(-0.31%) $10.95
USD/GBP
(-0.46%) $0.799
USD/RUB
(-0.16%) $92.18

Realtime updates for Natera Inc [NTRA]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
BUY
70.00%
return 14.55%
SELL
44.90%
return -13.24%
Last Updated24 Apr 2024 @ 16:00

0.51% $ 91.50

SELL 1017 min ago

@ $92.53

Issued: 24 Apr 2024 @ 13:22


Return: -1.11%


Previous signal: Apr 24 - 12:13


Previous signal: Buy


Return: 0.85 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):
Profile picture for Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle...

Stats
Today's Volume 835 688
Average Volume 1.43M
Market Cap 10.90B
EPS $0 ( 2024-02-28 )
Next earnings date ( $-0.710 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -20.47
ATR14 $2.23 (2.43%)
Insider Trading
Date Person Action Amount type
2024-04-21 Sheena Jonathan Buy 143 Common Stock
2024-04-20 Sheena Jonathan Buy 190 Common Stock
2024-04-20 Sheena Jonathan Sell 190 Restricted Stock Unit
2024-04-21 Sheena Jonathan Sell 143 Restricted Stock Unit
2024-04-21 Rabinowitz Daniel Buy 644 Common Stock
INSIDER POWER
-61.09
Last 100 transactions
Buy: 170 631 | Sell: 704 958

Volume Correlation

Long: -0.91 (very strong negative)
Short: -0.81 (strong negative)
Signal:(28) Be Aware. Possible trading coming up! (swing)

Natera Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Natera Inc Correlation - Currency/Commodity

The country flag 0.50
( weak )
The country flag 0.54
( weak )
The country flag 0.00
( neutral )
The country flag 0.25
( neutral )
The country flag 0.68
( moderate )
The country flag -0.55
( weak negative )

Natera Inc Financials

Annual 2023
Revenue: $1.08B
Gross Profit: $492.74M (45.52 %)
EPS: $-3.78
Q4 2023
Revenue: $311.11M
Gross Profit: $159.86M (51.38 %)
EPS: $-0.650
Q3 2023
Revenue: $268.31M
Gross Profit: $121.00M (45.10 %)
EPS: $-0.950
Q2 2023
Revenue: $261.40M
Gross Profit: $118.26M (45.24 %)
EPS: $-0.970

Financial Reports:

No articles found.

Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators